17 Sep An International Infographics On Poultry Drugs Market Share, Size And Analytics
Global Poultry Drugs Market
Precision Business Insights (PBI) in its report titled “Global Poultry Drugs Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Poultry drugs are chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others.
Increase in the demand for healthy meat and poultry products, rise in prevalence of various infectious diseases such as avian influenza, rise in R&D activities for the innovation of newer drugs, and increase in animal healthcare expenditure are expected to bolster the poultry drugs anticoccidial market. Moreover, government initiations for protecting the poultry industry, innovation of newer drugs and vaccines, and increase in the number of poultry farms are expected to bolster the global poultry antiviral drugs market. However, stringent regulatory guidelines for the product approval, adverse effects associated with drugs, lack of awareness about the poultry diseases in underdeveloped countries, and high R&D expenditure may impede the growth of global poultry drugs market.
The global poultry drugs market is divided into following categories-
- Drug type
- Anti-inflammatory Drugs
- Animal type
And lastly, on the basis of geographical regions, the global poultry drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa regions. North America poultry anticoccidial drugs market is growing at a significant rate, which is attributed to rise in demand for healthy meat and poultry products, launching of newer products into the market, and increase in awareness about the poultry diseases. Europe poultry vaccines market has a lucrative growth owing to rise in prevalence of various diseases such as avian flu, rise in animal welfare expenditure, and increase in the R&D activities for the innovation of newer drugs are bolster the market. Asia Pacific poultry vaccines market is poised to grow at significant rate due to increase in trading of meat and other poultry products from India and China, rise in number of poultry farms, and adoption of newer drugs and vaccines. Latin America poultry antiviral drugs market is rising due to positive economic growth, rise in animal welfare expenditure, and launching of newer products by the companies in the region. Middle East and Africa poultry anticoccidial drugs market exhibiting a prominent growth rate owing to expansion of business by the market players, rise in prevalence of infectious diseases, and increase in awareness about poultry diseases are boost the market.
Some of the key players in the global poultry antiviral drugs market include Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Phibro Animal health Corporation (U.S.), Zydus AHL (India), Ceva Sante Animale (France). Some of the market developments include Elanco launched Inteprity (avilamycin) for the prevention of necrotic enteritis in broiler chickens in 2016.